Aenova

About Aenova

The Aenova Group is one of the worlds largest providers of services covering the entire value chain for the development and production of all the main dosage forms and product groups in the field of medicines and dietary supplements. As the European business-to-business market leader, the Aenova Group focuses on high standards of quality, innovative technologies and a clear vision for the future. 

  • DE
  • 2017
    On CPHI since
Contact info
Meet us at

CPHI North America 2024

Pennsylvania Convention Center, Philadelphia
07 May 2024 - 09 May 2024

Products from Aenova (3)

  • Aenova CDMO Manufacturing Services INtro

    Product Aenova CDMO Manufacturing Services INtro

    With 15 production sites in Europe and the USA, the Aenova Group offers a broad range of dosage forms for Pharmaceutical and Consumer Health products. Our sites are equipped with the latest production technologies and have proven expertise to support your product needs with the highest quality and reliabil...
  • Aenova Softgel Manufacturing Services

    Product Aenova Softgel Manufacturing Services

    Aenova has more than 35 years of experience in the formulation and analytical development and production of soft gelatin capsules.

    Our production facilities are equipped with state-of-the-art equipment to process any formulation and any capsule design, color and size.

    With development...
  • Aenova Sterile Fill Finish & PFS manufacturing

    Product Aenova Sterile Fill Finish & PFS manufacturing

    The Aenova Group is a premier solution partner for sterile dosage forms with 3 FDA approved facilities offering high quality injectables for human health and animal health products.

    Our Sterile services include specialized capabilities for:

    Beta-lactams (penicillins, cephalosporins)In...

Aenova Resources (2)

  • News Aenova expands portfolio with innovative technologies

    The development of new drug products for a wide range of therapeutic areas is a rapidly growing market. Therefore, a smart innovation strategy is essential for contract developers and manufacturers. Aenova is expanding its development and production portfolio, particularly in the area of bioavailability of active pharmaceutical ingredients.